Antigenic heterogeneity in patients with reactions in borderline leprosy
- PMID: 53086
- PMCID: PMC1675388
- DOI: 10.1136/bmj.4.5994.435
Antigenic heterogeneity in patients with reactions in borderline leprosy
Abstract
Fifteen patients with borderline leprosy who developed "reversal" reactions were studied from the inception of treatment. Thirteen showed an appreciable increase in lymphocyte transformation (LT) when preparations of Mycobacterium leprae were used as antigen. The LT responses to either "whole" or "sonicated" preparations of the bacillus in these 15 patients and in nine others also in reaction correlated with the clinical presentation. Those with skin disease predominating in the reaction showed an appreciable increase in LT when whole M leprae was used as antigen. Those with nerve disease predominating showed an increase with sonicated M leprae. In those with both skin and nerve disease there was an increase with both antigen preparations. The ratios of the LT test results (whole to sonicated M leprae) showed highly significant differences between the three groups.
Similar articles
-
Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.Clin Exp Immunol. 1976 Jul;25(1):85-94. Clin Exp Immunol. 1976. PMID: 791549 Free PMC article.
-
T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.Int J Lepr Other Mycobact Dis. 1992 Mar;60(1):44-53. Int J Lepr Other Mycobact Dis. 1992. PMID: 1602193
-
Lymphocyte transformation test in healthy contacts of patients with leprosy. I. Influence of exposure to leprosy within a household.Int J Lepr Other Mycobact Dis. 1979 Jun;47(2):138-52. Int J Lepr Other Mycobact Dis. 1979. PMID: 378871
-
HLA and leprosy in the pre and postgenomic eras.Hum Immunol. 2006 Jun;67(6):439-45. doi: 10.1016/j.humimm.2006.03.009. Epub 2006 Apr 3. Hum Immunol. 2006. PMID: 16728267 Review.
-
Experiences with Mycobacterium leprae soluble antigens in a leprosy endemic population.Lepr Rev. 1990 Jun;61(2):132-44. Lepr Rev. 1990. PMID: 2198413 Review.
Cited by
-
Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control.Clin Exp Immunol. 1983 Nov;54(2):289-97. Clin Exp Immunol. 1983. PMID: 6228348 Free PMC article. Review. No abstract available.
-
High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy.Clin Exp Immunol. 2002 May;128(2):333-8. doi: 10.1046/j.1365-2249.2002.01791.x. Clin Exp Immunol. 2002. PMID: 11985524 Free PMC article.
-
The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.Clin Exp Immunol. 1980 Sep;41(3):406-14. Clin Exp Immunol. 1980. PMID: 7002396 Free PMC article.
-
Ultrastructural changes in blood vessels of peripheral nerves in leprosy neuropathy. II. Borderline, borderline-lepromatous and lepromatous leprosy patients.Acta Neuropathol. 1977 Sep 26;40(1):21-39. doi: 10.1007/BF00688570. Acta Neuropathol. 1977. PMID: 199033 No abstract available.
-
Lymphocyte transformation test in leprosy: decreased lymphocyte reactivity to Mycobacterium leprae in lepromatous leprosy, with no evidence for a generalized impairment.Infect Immun. 1978 Dec;22(3):649-56. doi: 10.1128/iai.22.3.649-656.1978. Infect Immun. 1978. PMID: 153335 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources